CHECKPOINT THERAPEUTICS INC
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 millionSun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal invo...
Jubilant Life signs $180 mn outlicensing deal with Checkpoint"The pact includes an upfront payment of $2 mn and contingent pre-clinical, clinical and regulatory payments including commercials up to $1...
- Load More